Concepedia

Ana M. Ortega‐Villa

AM

14

Publications

451

Citations

12

H-Index

2017

Active since

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Frederick National Laboratory for Cancer Research

Institute for Social Security and Services for State Workers

Leidos Biomedical Research Inc. (United States)

Ana M. Ortega‐Villa is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2017–2024

14

Publications

14

Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States

Gloria Hong, Ana M. Ortega‐Villa, Sally Hunsberger et al. · Clinical Infectious Diseases · 2019 · 108 citations · Full text

, , +20

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Tracy J. Ruckwardt, Kaitlyn M. Morabito, Emily Phung et al. · The Lancet Respiratory Medicine · 2021 · 62 citations · Full text

, , +6

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

Melinda Hamer, Katherine V. Houser, Amelia R. Hofstetter et al. · The Lancet · 2023 · 62 citations · Full text

, , +9

Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States

Adriana Marques, Grace M. Okpali, Kelly Liepshutz et al. · Annals of Clinical and Translational Neurology · 2022 · 34 citations · Full text

Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years

Andrea Lisco, Ana M. Ortega‐Villa, Harry Mystakelis et al. · New England Journal of Medicine · 2023 · 32 citations · Full text

Rows per page

1–5 of 14